Optimized Treatment of Peginterferon Alfa 2a in Treatment Experienced Patients With HBV Related Liver Fibrosis

NCT03957629 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

186

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B
Liver Fibrosis

Interventions

DRUG: Tenofovir Disoproxil Fumarate
DRUG: PEG-Interferon alfa 2a

Sponsor

Third Affiliated Hospital, Sun Yat-Sen University